Kinder Morgan, Inc. (KMI) Presents at 2025 Wells Fargo 24th Annual Energy and Power Symposium Transcript — Neutral
KMI Seeking Alpha — December 09, 2025Kinder Morgan, Inc. (KMI) Presents at 2025 Wells Fargo 24th Annual Energy and Power Symposium Transcript
T-Mobile US, Inc. (TMUS) Presents at UBS Global Media and Communications Conference 2025 Transcript — Neutral
TMUS Seeking Alpha — December 09, 2025T-Mobile US, Inc. (TMUS) Presents at UBS Global Media and Communications Conference 2025 Transcript
Star Group, L.P. Common Units (SGU) Q4 2025 Earnings Call Transcript — Neutral
SGU Seeking Alpha — December 09, 2025Star Group, L.P. Common Units (SGU) Q4 2025 Earnings Call Transcript
Can Subscription Services Power MSTR's Long-Term Software Growth? — Positive
MSTR Zacks Investment Research — December 09, 2025Strategy's surging subscription revenues are emerging as a key stabilizer for its software business despite uneven legacy performance.
Are You Looking for a High-Growth Dividend Stock? — Positive
BMO Zacks Investment Research — December 09, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bank of Montreal (BMO) have what it takes?
Why Toronto-Dominion Bank (TD) is a Great Dividend Stock Right Now — Positive
TD Zacks Investment Research — December 09, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Toronto-Dominion (TD) have what it takes?
MLTX 6-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman — Neutral
MLTX PRNewsWire — December 09, 2025Lead Partner Reed Kathrein Investigating Alleged Undisclosed Truth: Did SLK's Nanobody Structure Truly Confer a Superior Clinical Benefit Over Monoclonal Antibodies? SAN FRANCISCO , Dec. 9, 2025 /PRNewswire/ -- Global plaintiffs' rights law firm Hagens Berman reminds investors that the deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit against MoonLake Immunotherapeutics, Inc. (NASDAQ: MLTX) is December 15, 2025.
Nvidia Wins Trump's Approval to Sell H200 AI Chips to China, But There's a Catch — Positive
NVDA Investopedia — December 09, 2025Nvidia could be set to sell more of its advanced chips to China, with some conditions.
Brookfield CEO Bruce Flatt on $20 billion partnership with Qatar — Positive
BAM CNBC Television — December 09, 2025CNBC's Leslie Picker sits down with Brookfield CEO Bruce Flatt to discuss the company's new partnership with the Qatar Investment Authority, its AI strategy, and more.
Disruptive Theme of the Week: Top 3 Heavy Metal Themes YTD — Neutral
MUSQ ETF Trends — December 09, 2025As we head into the end of the year, heavy metal investment themes have emerged as big winners in 2025. When investors think “heavy metal,” they might be looking for exposure in the MUSQ Global Music Industry ETF (MUSQ).
Can Datadog's Accelerating Security ARR Power Its Next Leg of Growth? — Positive
DDOG Zacks Investment Research — December 09, 2025DDOG's fast-growing security ARR spotlights how its broadened security layers can shape the company???s next major growth leg.
5 Home Furnishing Stocks Set to Benefit From an Industry Upswing — Positive
FGI FND HVT SGI WSM Zacks Investment Research — December 09, 2025A focus on digitization, e-commerce, product innovation and new marketing techniques is encouraging for industry players like WSM, SGI, FND, HVT and FGI despite macro headwinds.
Community Health Systems Stock Falls 7% Amid Debt & Other Pressures — Negative
CYH Zacks Investment Research — December 09, 2025Shares of CYH decline 7%. Heavy debt, soft patient volumes and ongoing investor concerns keep pressure on the hospital operator.
FLS vs. NDSN: Which Stock Is the Better Value Option? — Neutral
FLS NDSN Zacks Investment Research — December 09, 2025Investors looking for stocks in the Manufacturing - General Industrial sector might want to consider either Flowserve (FLS) or Nordson (NDSN). But which of these two stocks offers value investors a better bang for their buck right now?
S&P 500: 2026 Is Likely To Be A Year Of Consolidation — Neutral
IVV SPLG SPXL SPY SSO UPRO VOO Seeking Alpha — December 09, 2025The S&P 500 is projected to end 2026 near its current level of 6,850, reflecting a consolidation period. Despite a current P/E premium of 10–12% over historical averages, robust EPS growth to a record $309.22 is expected in 2026.
TD vs. IBN: Which Stock Is the Better Value Option? — Positive
IBN TD Zacks Investment Research — December 09, 2025Investors interested in Banks - Foreign stocks are likely familiar with Toronto-Dominion Bank (TD) and ICICI Bank Limited (IBN). But which of these two companies is the best option for those looking for undervalued stocks?
RIO or WPM: Which Is the Better Value Stock Right Now? — Positive
RIO WPM Zacks Investment Research — December 09, 2025Investors interested in Mining - Miscellaneous stocks are likely familiar with Rio Tinto (RIO) and Wheaton Precious Metals Corp. (WPM). But which of these two stocks presents investors with the better value opportunity right now?
NEM vs. RGLD: Which Stock Is the Better Value Option? — Positive
NEM RGLD Zacks Investment Research — December 09, 2025Investors interested in Mining - Gold stocks are likely familiar with Newmont Corporation (NEM) and Royal Gold (RGLD). But which of these two companies is the best option for those looking for undervalued stocks?
BIS says gold and equities are in bubble territory — Negative
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — December 09, 2025Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing — Neutral
SKYE PRNewsWire — December 09, 2025PHILADELPHIA , Dec. 9, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye" or the "Company") on behalf of investors who purchased or otherwise acquired Skye securities during the period of November 4, 2024 through October 3, 2025 (the "Class Period"), inclusive. Investor Deadline: Investors who purchased Skye securities during the Class Period may, no later than January 16, 2026 , seek to be appointed as a lead plaintiff representative of the class.